Century Therapeutics Inc (IPSC)

06:35 AM

What drives Century Therapeutics Inc. stock priceHigh-yield portfolio picks - PrintWeekIndia

06:35 AM

Jul 24, 2025

What analysts say about Century Therapeutics Inc. stockJaw-dropping returns - PrintWeekIndia

Jul 24, 2025

Jul 24, 2025

Layoff Tracker: Flagship Unicorns Tessera, Generate:Biomedicines Downsize - BioSpace

Jul 24, 2025

Jul 23, 2025

Century Therapeutics Inc. Stock Analysis and ForecastTremendous growth potential - Autocar Professional

Jul 23, 2025

Jul 21, 2025

All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy - Yahoo Finance

Jul 21, 2025

Jul 20, 2025

Is Century Therapeutics Inc. a good long term investmentMarket-leading capital gains - jammulinksnews.com

Jul 20, 2025

Jul 18, 2025

What institutions are buying Century Therapeutics Inc. stock nowFree Step-by-Step Investment Guide - Newser

Jul 18, 2025

Jul 16, 2025

University City biotech Century Therapeutics is cutting 72 jobs, about half its workforce - MSN

Jul 16, 2025

Jul 15, 2025

Why Century Therapeutics Inc. stock attracts strong analyst attentionMarket Trend Watch - Newser

Jul 15, 2025

Jul 15, 2025

Finance Watch: Karyopharm Cuts Jobs In Cash Crunch; Pacira’s Layoffs Attributed To Efficiency - insights.citeline.com

Jul 15, 2025

Jul 15, 2025

Century Therapeutics to Present Preclinical Data at EULAR 2025 Congress - MSN

Jul 15, 2025

Jul 15, 2025

How Century Therapeutics Inc. stock performs during market volatilityFree Stock Market Query - Newser

Jul 15, 2025

Jul 15, 2025

What makes Century Therapeutics Inc. stock price move sharplyRisk Limited High Gain Trades - Newser

Jul 15, 2025

Jul 15, 2025

Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock - Yahoo Finance

Jul 15, 2025

Jul 15, 2025

Why OBIO stock attracts strong analyst attentionHigh Yield Stock Selection - Newser

Jul 15, 2025

Jul 10, 2025

Company’s Banking Stock: Dissecting a 51.83% Quarterly Revenue Decline Amid Growth - investchronicle.com

Jul 10, 2025

Jul 08, 2025

Century Therapeutics (NASDAQ:IPSC) Shares Down 0.9% – What’s Next? - Defense World

Jul 08, 2025

Jul 07, 2025

CFO changes at Biocryst, Xenon, Century, Pyxis - biocentury.com

Jul 07, 2025

Jul 07, 2025

Century Therapeutics to reduce headcount by 51% - MarketScreener

Jul 07, 2025

Jul 07, 2025

Century Therapeutics Announces Major Workforce Reduction - TipRanks

Jul 07, 2025

Jun 25, 2025

Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum - Nasdaq

Jun 25, 2025

Jun 20, 2025

Head-To-Head Contrast: Quince Therapeutics (NASDAQ:QNCX) and Century Therapeutics (NASDAQ:IPSC) - Defense World

Jun 20, 2025

Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting By Investing.com - Investing.com South Africa

Jun 16, 2025

Jun 16, 2025

Century Therapeutics Holds Annual Stockholder Meeting - Investing.com Australia

Jun 16, 2025

Jun 16, 2025

Century Therapeutics Holds 2025 Annual Stockholders Meeting - TipRanks

Jun 16, 2025

Jun 14, 2025

66,797 Shares in Century Therapeutics, Inc. (NASDAQ:IPSC) Acquired by Two Sigma Investments LP - Defense World

Jun 14, 2025

Jun 10, 2025

Jane Street Group LLC Increases Stock Holdings in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 10, 2025

Jun 09, 2025

Century Therapeutics, Inc. (NASDAQ:IPSC) Shares Acquired by Squarepoint Ops LLC - Defense World

Jun 09, 2025

Jun 09, 2025

Two Sigma Advisers LP Takes $52,000 Position in Century Therapeutics, Inc. (NASDAQ:IPSC) - Defense World

Jun 09, 2025